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Background: Significant immunomodulatory effects have been described as result of cigarette smoking in adults
and pregnant women. However, the effect of cigarette smoking during pregnancy on the lymphocyte
subpopulations in newborns has been discussed, controversially.
Methods: In a prospective birth cohort, we analyzed the peripheral lymphocyte subpopulations of smoking (SM)
and non-smoking mothers (NSM) and their newborns and the replicative history of neonatal, mostly naive CD4 +
CD45RA + T cells by measurements of T-cell-receptor-excision-circles (TRECs), relative telomere lengths (RTL) and the
serum cytokine concentrations.
Results: SM had higher lymphocyte counts than NSM. Comparing SM and NSM and SM newborns with NSM
newborns, no significant differences in proportions of lymphocyte subpopulations were seen. Regardless of their
smoking habits, mothers had significantly lower naive T cells and higher memory and effector T cells than
newborns. NSM had significantly lower percentages of CD4 + CD25++ T cells compared to their newborns, which
was not significant in SM. There were no differences regarding cytokine concentrations in newborns of SM and
NSM. However, NSM had significantly higher Interleukin-7 concentrations than their newborns. Regardless of
smoking habits of mothers, newborns had significantly longer telomeres and higher TRECs than their mothers.
Newborns of SM had significantly longer telomeres than newborns of NSM.
Conclusions: Apart from higher lymphocyte counts in SM, our results did not reveal differences between lymphocyte
subpopulations of SM and NSM and their newborns, respectively. Our finding of significantly longer RTL in newborns
of SM may reflect potential harm on lymphocytes, such as cytogenetic damage induced by smoking.
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Significant alterations of the lymphocyte proportions
[1,2] and higher inflammatory cytokines, such as IL-1β,
IL-4, IL-6 and TGF-β [3-5], and lower TNF-α, IL-2 and
IFN-γ concentrations [6] have been described as result
of cigarette smoking in healthy individuals [7]. Smoking
during pregnancy has been shown to be an independent
risk factor for respiratory diseases in children [8]. For* Correspondence: Prelog_M@kinderklinik.uni-wuerzburg.de
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reproduction in any medium, provided the orpregnant women, increase of NK cells and inflammatory
macrophages, as well as lower percentages of regulatory
T cells (Tregs) have been reported, with lower birth
weights in their neonates [9]. Most knowledge about the
role of cigarette smoking on the composition of the
different lymphocyte subpopulations in neonates has
been generated from studies in mice, in which a controlled
exposure to a defined component of tobacco smoke
was performed. A significant reduction of newborn
CD4 + CD8+, CD4 + CD8+ V beta 8+ thymocytes and
CD4+ splenocytes from 1-week-old progeny was shown in
mice exposed to benzo[a]pyrene, a critical component of
cigarette smoke [10]. In a study investigating 14 newbornsal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with a most prominent decrease in segmented neutrophils,
monocytes and lymphocytes were found compared to 74
newborns of non-smoking mothers [11].
According to results from adult smokers, pregnant
smoking women and prenatally cigarette-smoke exposed
newborns, our hypothesis was that components of cigarette
smoke may cause distress on fetal lymphocytes, resulting
in higher differentiation of T cell subpopulations, less
naive T cells, a higher replicative history of peripheral T
cells, as measured by T cell receptor excision circles
(TRECs) [12,13] and relative telomere length [14], and
higher pro-inflammatory cytokines, such as IL-1β, IL-6 or
TNF-α. IL-7 is seen as a cytokine inducing peripheral
naive T cell proliferation.
Thus, the present, prospective birth cohort was aimed
to analyze the peripheral lymphocyte subpopulations of
smoking (SM) and non-smoking mothers (NSM) and
their newborns, the replicative history of neonatal,
mostly naive CD4 + CD45RA + T cells and the serum
cytokine concentrations.
Methods
Study participants
Smoking (SM) and non-smoking mothers (NSM) and
their newborns were recruited at the Department of
Gynecology and Obstetrics, Medical University Innsbruck,
Austria, after giving written informed consent. The study
was approved by the local ethics committee and was
performed according to the principles of good clinical and
laboratory practice and the Declaration of Helsinki.
Only Caucasian mothers were included who were healthy
without underlying medical conditions or medications
and who had uncomplicated, spontaneous vaginal delivery
of a healthy, mature newborn (showing at least 5 maturity
signs according to [15]) between gestational weeks 37 and
42. The SM group was defined by both a history of cigarette
smoking during pregnancy and by positive cotinine
concentrations >25 ng/ml from venous blood sampling at
admission to the maternity ward (2 to 24 hours before
birth). The mothers were asked about their smoking
behavior using a standardized questionnaire, including the
number of smoked cigarettes before and during pregnancy
and the brand and nicotine strength of the smoked
filter-tipped or non-filter cigarettes. The addictive behavior
was controlled by Fagerström test for nicotine dependence
questionnaire [16]. Maternal exclusion criteria were: atopy,
autoimmune disorders, malignancies, chronic organ
insufficiency, drugs, alcohol during pregnancy, medications,
high blood pressure (systolic blood pressure >150 mmHg),
eclampsy, diabetes during pregnancy, positive bacterial
vaginal swab in the last 3 weeks before delivery, antibiotics
in the last 3 weeks before delivery or during delivery,
vacuum extraction and passive smoking in the NSM group.Neonatal exclusion criteria were: pathological cardio-
tocogram, APGAR score < 9 in the first minute, brady-
cardia (< 100/minute), tachydyspnea (frequency breath
taking >60/min), signs of infection or fetal distress (e.g.
green-stained amniotic fluid) and congenital syndromes.
Cord blood was collected between 1 and 5 minutes after
birth.
Lymphocyte isolation and characterization
Lymphocytes from venous blood or cord blood were
isolated using Biocoll Separating Solution (Biochrom
AG, Berlin, Germany). Lymphocyte subpopulations
were measured by fluorochrom-labeled antibodies (all
purchased from BD Pharmigen, San Jose, CA, USA)
with flowcytometry according to following definitions:
CD3+ (T cells), CD19+ (B cells), CD16+/CD56+ (NK cells),
CD45RA +CD28 +CD62L + (naive T cells), CD45RO+
CD27 +CD28+ (early memory T cells), CD45RO+CD27-
CD28- (late memory T cells), CD45RA +CD28- (effector
T cells), CD4 + CD25++ (bright) (representing features of
naive T cells, regulatory T cells, Tregs, and activated T
cells). Results were expressed as percentages of gated
lymphocytes.
Quantification of TRECs and relative telomere length
DNA was extracted from separated CD4+CD45RA+ T cells
using QIAamp DNA Mini Kit (Qiagen, Chatsworth, CA,
USA). Signal-joint TREC concentrations were determined
by quantitative SYBR-green real-time PCR based on the
coding TREC sequence using an iCycler quantitative
RT-PCR system (BioRad Laboratories, Hercules, Canada)
and log2 dilutions of an internal standard as described
previously [12,17]. To avoid bias by different numbers
of naive T cells, TRECs were calculated in relation to
CD4 + CD45RA + T cell numbers [13].
Determination of relative telomere length (RTL) was
performed by calculating the ratio of a quantitative PCR
reaction product from the same sample using specific
primers for telomeres and a single copy gene as described
previously [14,18].
Cytokine measurements
ELISAs for measurements of IL-1β, IL-2, IL-4, IL-6, IL-7,
IL-8, IL-10 and TNF-α were performed according to
the manufacturer’s instructions (R&D Systems Europe,
Minneapolis, MN, USA).
Cotinine concentrations
Cotinine concentrations in serum from maternal venous
blood and cord blood were measured using a commercial
ELISA (DRG International, Marburg, Germany). Cotinine
concentrations higher than 25 ng/ml were defined to
be positive.
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Distribution of data was tested by Kolmogorov-Smirnov
test using SPSS Version 19.0 (Chicago, IL, USA). Normally
distributed data were analyzed with student’s T test, not
normally distributed data with Mann–Whitney-U test.
Multiple linear regression analysis was performed in
search for independent variables, including maternal
smoking, age of mother at birth, gestational week, male or
female gender, birth weight, birth length, head circumference
and APGAR at 1 and 5 minutes. A p-value < 0.05 was
considered to be statistically significant.Results
Epidemiological characteristics of mothers and their
newborns
There was no significant difference between non-smoking
mothers (NSM) and smoking mothers (SM) regarding
age (Table 1). SM reduced their cigarette consumption
during pregnancy to 61.5% in the first, 57.0% in the
second and 58.5% in the third trimenon. The mean
birthweight of SM newborns was significantly lower
than that of their NSM counterparts (Table 1). SM
had more male newborns (63.8%) than NSM (54.1%)
(Table 1).
Of SM, 24 smoked light cigarettes (nicotine content
between 0.6 to 1.0 mg), 31 smoked normal cigarettes
(nicotine content between 1.2 to 1.4 mg) and 3 smoked
light and normal cigarettes. The mean maternal cotinine
concentrations were 42.6 ± 7.0 ng/ml. The mean neo-
natal cotinine concentrations were 42.9 ± 6.6 ng/ml.
Fagerström questionnaire revealed 2 to 5 points (moderate
addiction) in 35 SM, 6 to 11 points (strong addiction)
in 23 SM.Table 1 Epidemiological characteristics of mothers and newb
Non-smoking mothe
Maternal age at birth (years) 31.1 ± 5.7 (31.2;
Cigarettes/day before pregnancy (n = 10) 11.3 ± 7.3
Years of tobacco use 9.0 ± 4.4 (10.0;
First trimenon (cigarettes/day) 0
Second trimenon (cigarettes/day) 0
Third trimenon (cigarettes/day) 0
Sex of newborn (male/female) (number) 60/5
Gestational age (weeks) 39.6 ± 1.4 (39.1;
Birth weight (g) 3379.3 ± 429.9 (3380.0
Birth length (cm) 50.4 ± 2.0 (51.0;
Head circumference (cm) 35.0 ± 1.3 (35.0;
Values are given in mean ± standard deviation (median; range). Numbers of subject
Statistical differences (non-parametric Mann–Whitney-U test):
*** p < 0.001: higher than NSM value.
Statistical difference (parametric Student’s T test):
***1) p < 0.001: lower than NSM values.
* 2) p < 0.05: lower than NSM value.Blood cell counts and percentages of lymphocyte
subpopulations
SM had significantly lower platelet counts (182.8 ± 46.3 G/l)
than NSM (229.9 ± 47.1 G/l), but higher lymphocyte
counts (Table 2). There were no significant differences
in red blood cell counts between newborns of SM
and NSM.
Comparing the whole groups of SM and NSM, no
significant differences in proportions of lymphocyte
subpopulations in mothers or newborns were seen
(Table 2). There were no differences between the sub-
groups of SM smoking light or normal cigarettes and
between SM with moderate and strong addiction
according to Fagerström questionnaire. Regardless of
their smoking habits, mothers had significantly lower
proportions of naive T cells, higher proportions of memory
T cells, of early and late memory T cells and of effector T
cells than their newborns. NSM had significantly lower
percentages of CD4 + CD25++ T cells compared to their
newborns, which was not significant in SM.
Analysis of the data of the subjects of the NSM group
who smoked prior to pregnancy and comparison of
these subjects to the SM group who continued smoking
during pregnancy and the NSM group who never smoked
did not reveal any differences.Cytokine concentrations
There were no significant differences regarding cytokine
concentrations in newborns of SM and NSM (Table 3).
However, NSM had significantly higher IL-7 concentrations
than their newborns (Figure 1). Also, SM showed a trend
to higher IL-7 concentrations compared to their newborns
(p = 0.07) (Figure 1).orns
rs (NSM) (n = 111) Smoking mothers (SM) (n = 58)
16.0 – 46.4) 29.0 ± 6.0 (28.2; 18.5 – 40.4)
(12.0; 1.5 -20.0) (n = 58) 20.0 ± 9.3 (20.0; 2.0 – 40.0)***
2.0 – 20.0) 11.5 ± 5.7 (10.0; 2.0 – 24.0)
12.3 ± 7.1 (10.0; 2.0 – 30.0)
11.4 ± 6.8 (10.0; 2.0 – 30.0)
11.7 ± 7.3 (10.0; 1.0 – 30.0)
1 37/21
37.3 – 41.7) 39.5 ± 1.5 (39.4; 37.1 – 41.7)
; 2330.0 – 4355.0) 3118.2 ± 497.7 (3040.0; 2190.0 – 4190.0)***1)
46.0 – 57.0) 49.1 ± 2.7 (49.0; 43.0 – 55.0)*** 1)
32.0 – 38.0) 34.3 ± 1.2 (35.0; 32.0 – 37.0)* 2)
s, n.
Table 2 Lymphocyte subpopulations in newborns and non-smoking (NSM) and smoking mothers (SM)
Newborns Mothers
NSM (n = 111) SM (n = 58) NSM (n = 111) SM (n = 58)
Leucocytes/μl 11948 ± 3771 (11340; 5440 – 23980) 11285 ± 2796 (11600; 4570 – 16810) 11863 ± 5040 (11180; 4140 – 25510) 13404 ± 4390 (12700; 6980 – 21520)
Lymphocytes/μl 4084 ± 1263 (3800; 1580 – 8500) *** 4046 ± 1057 (3930; 2320 – 6100)*** 1277 ± 493 (1250; 480 – 2660) 1897 ± 722 (1810; 900 – 4260) ***1)
CD3+ (% of lymphocytes) 69.2 ± 8.8 (69.4; 51.6 – 86.7) 68.8 ± 8.7 (68.3; 50.5 – 90.3) 80.1 ± 6.9 (80.8; 56.6 – 91.6) 79.8 ± 6.9 (80.3; 62.1 – 91.6)
CD19+ (% of lymphocytes) 16.9 ± 6.2 (15.2; 5.0 – 35.1) 18.2 ± 4.9 (18.4; 8.6 – 26.3) 10.2 ± 4.3 (9.3; 2.8 – 24.4) 12.1 ± 5.5 (11.5; 4.6 – 27.5)
CD16+/56+ (% of lymphocytes) 13.8 ± 8.5 (11.4; 3.0 – 39.5) 13.1 ± 7.6 (12.5; 1.1 – 26.5) 9.7 ± 7.0 (7.8; 1.9 – 38.6) 8.1 ± 4.7 (7.6; 1.7 – 25.1)
CD4/CD8 2.5 ± 0.9 (2.4; 0.9 – 5.0) 2.4 ± 0.7 (2.4; 1.3 – 3.8) 1.7 ± 0.6 (1.6; 0.7 – 3.2) 1.8 ± 0.6 (1.7; 0.9 – 3.9)
CD4+ (% of CD3+) 69.7 ± 8.1 (70.8; 48.8 – 83.4) 69.5 ± 6.0 (70.1; 56.3 – 79.3) 61.2 ± 8.0 (61.5; 41.9 – 75.9) 61.9 ± 7.9 (63.3; 46.4 – 79.8)
CD8+ (% of CD3+) 30.4 ± 8.1 (29.2; 16.6 – 51.2) 30.5 ± 6.1 (29.8; 20.7 – 43.8) 38.8 ± 8.0 (38.5; 23.9 – 58.0) 38.0 ± 7.9 (36.7; 20.3 – 53.6)
CD45RA + CD28 + CD62L + (% of CD4+) 85.3 ± 8.9 (85.4; 48.4 – 94.8) 86.7 ± 6.6 (87.5; 70.8 – 98.6) 45.1 ± 14.1 (45.6; 19.5 – 62.4) ***2) 42.4 ± 12.1 (44.1; 20.6 – 67.2) ***2)
CD45RA + CD28 + CD62L + (% of CD8+) 59.3 ± 12.9 (58.9; 20.5 – 85.7) 60.5 ± 10.9 (59.1; 31.6 – 77.3) 38.8 ± 17.6 (36.9; 12.0 – 83.3) ***2) 37.4 ± 11.5 (38.8; 11.2 – 59.0) ***2)
CD45RO + CD27 + CD28+ (% of CD4+) 4.9 ± 2.4 (4.7; 0.5 – 11.9) ***3) 4.7 ± 1.9 (4.8; 0.6 – 9.2) ***3) 34.3 ± 10.6 (33.1; 14.2 – 65.2) 37.1 ± 8.5 (38.5; 17.6 – 51.0)
CD45RO + CD27 + CD28+ (% of CD8+) 3.4 ± 1.7 (3.4; 0.0 – 9.3) ***3) 3.1 ± 1.8 (3.1; 0.0 – 7.2) ***3) 13.4 ± 7.6 (11.8; 3.2 – 49.1) 12.1 ± 5.8 (10.4; 3.7 – 24.5)
CD45RO + CD27-CD28-(% of CD4+) 0.3 ± 0.5 (0.1; 0.0 – 2.5) ***3) 0.4 ± 0.5 (0.1; 0.0 – 2.0) ***3) 2.1 ± 3.1 (0.7; 0.1 – 18.1) 1.5 ± 2.4 (0.6; 0.1 – 11.1)
CD45RO + CD27-CD28-(% of CD8+) 0.3 ± 0.7 (0.1; 0.0 – 4.3) ***3) 0.2 ± 0.4 (0.0; 0.0 – 2.0) ***3) 4.0 ± 6.4 (2.5; 0.1 – 22.0) 2.8 ± 3.5 (1.8; 0.1 – 18.6)
CD45RA + CD28- (% of CD4+) 0.05
± 0.2 (0.0; 0.0 – 1.7) ***3)
0.02 ±0.04 (0.0; 0.0 – 0.1) ***3) 1.0 ± 1.8 (0.2; 0.1 – 7.8) 0.9 ± 2.4 (0.2; 0.1 – 11.9)
CD45RA + CD28- (% of CD8+) 3.3 ± 4.9 (2.4; 0.3 – 4.8) ***3) 2.2 ± 1.1 (2.3; 0.1 – 6.1) ***3) 16.9 ± 12.9 (14.6; 0.4 – 57.9) 16.7 ± 11.9 (13.8; 1.0 – 40.9)
CD4 + CD25++ (% of CD3+) 6.1 ± 2.9 (6.6; 0.0 – 11.7) 6.0 ± 3.3 (7.3; 0.0 – 10.7) 5.4 ± 3.9 (5.2; 0.1 – 17.0)*4) 6.2 ± 4.7 (6.1; 0.1 – 17.7)
Values are given in mean ± standard deviation (median; range). Numbers, n.
Statistical differences (parametric Student’s T test):
*** p < 0.001: higher than respective maternal values.
Statistical differences (non-parametric Mann–Whitney-U test):
***1) p < 0.001: higher than NSM value.
***2) p < 0.001: higher than respective newborn values.
***3) p < 0.001: lower than respective maternal values.
*4) p < 0.05: lower than respective newborn value.
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Table 3 Cytokine concentrations in newborns of
non-smoking (NSM) and smoking mothers (SM)
Newborns
pg/ml NSM (n = 33) SM (n = 13)
IL-1β 87.5 ± 98.2 (52.0; 14.1 – 265.4) 87.6 ± 13.8 (80.8; 78.6 – 103.5)
IL-2 44.6 ± 51.1 (25.1; 5.0 – 91.9) 53.3 ± 14.0 (53.5; 22.1 – 73.7)
IL-4 26.2 ± 22.7 (16.2; 1.6 – 76.3) 18.8 ± 6.7 (17.5; 12.3 – 28.0)
IL-6 112.5 ± 204.8 (28.3; 0.6 – 737.8) 241.3 ± 408.2 (36.0; 7.4 – 1037.5)
IL-8 685.3 ± 1141.8
(166.4; 6.1 – 4474.5)
879.4 ± 1361.3
(41.6; 0.2 – 4352.4)
IL-10 6.3 ± 9.3 (2.9; 0.6 – 40.7) 3.5 ± 2.8 (2.7; 0.6 – 8.8)
IFN-γ 4.9 ± 3.6 (4.8; 0.1 – 12.8) 5.2 ± 3.2 (5.1; 1.1 – 9.8)
TNF-α 8.1 ± 8.7 (3.9; 1.3 – 29.2) 19.3 ± 32.6 (3.9; 1.3 – 89.1)
Values are given in mean ± standard deviation (median; range). Numbers, n.
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Regardless of smoking habits of mothers, newborns had
significantly higher TREC numbers and longer telomeres
than their mothers (Table 4). Comparing RTLs of
newborns, newborns of SM had significantly longer
telomeres than newborns of NSM (Figure 2). In multiple
regression analysis, adjustment for age of mother at birth,
gestational week, gender, birth weight, birth length, head
circumference and APGAR at 1 and 5 minutes did not
alter these results.
Discussion
Our prospective birth cohort study demonstrated no
significant influence of maternal cigarette smoking on
the percentages of lymphocyte subpopulations in
newborns. This was surprising as we expected alterations
of the proportions of lymphocytes in newborns of SMIL
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Figure 1 Interleukin-7 (IL-7) concentrations in non-smoking
(NSM) and smoking mothers (SM) and newborns. NSM had
significantly higher IL-7 concentrations than their newborns (** p < 0.01).
Non-parametric Mann–Whitney-U test.with higher replication rates of peripheral naive T cells,
estimated by TRECs and RTL, which was thought to be
caused by a pro-inflammatory potential of cigarette smoke
components. However, with the exception of longer RTLs
in newborns of SM, neither lymphocyte subpopulations,
nor TRECs or cytokine concentrations were significantly
different between newborns of SM and NSM.
Our findings were in contrast to a study showing
significantly lower leukocyte counts with a most promin-
ently decrease in segmented neutrophilic granulocytes,
monocytes and lymphocytes in neonates of smoking
mothers [11]. In that study, number of smoking mothers
was small (14 versus 74 non-smoking mothers) and ways
of delivery differed. In that study, neonatal distress (e.g.
meconium within amniotic fluid, postnatal supplemention
of oxygen), bacterial colonization or inflammation (e.g.
positive vaginal smear, premature rupture of membranes)
were not excluded, which may influence the investigated
parameters. However, our study confirmed the previously
found decrease in birth weight associated with maternal
smoking [19].
According to literature [12,20], mothers showed
significantly lower TRECs and shorter telomeres than their
neonates. Interestingly, newborns of SM demonstrated
longer telomeres than newborns of NSM. Telomere
lengths reflect the replicative history of each individual
cell, which implicates a lower replicative rate in CD4 +
CD45RA + T cells, in part also supported by a trend to
higher TREC numbers in newborns of SM. A recent study
showed significant cytogenetic damage of lymphocytes
with changes of the mitotic index in neonates of SM [21].
This is in agreement with the finding in our study of less
replication of CD4 + CD45RA + T cells, as suggested
by longer RTLs in this lymphocyte subpopulation. In
neonates, CD4 + CD45RA + T cells may represent the
naive T cell pool. In adults, not only naive T cells, but also
CD45RA + CD28- effector T cells contribute to the
CD4 + CD45RA + T cell pool [22]. Usually in adults,
these CD45RA + effector T cells are clonally exhausted and
are negative for TRECS with short telomeres. However,
CD45RA-expressing effector T cells can be neglected in
newborns. Short telomere lengths have been associated
with decreased lung function and increased risk of chronic
obstructive pulmonary disease in adult smokers, with the
association markedly attenuated after adjusting for age
and other confounders [23]. No effect of smoking on
RTL was seen in SM compared to NSM in our groups.
However, the mothers were younger than in that study
[23] and had no history of an impaired lung function or
chronic obstructive pulmonary disease. Additionally, as
demonstrated by that study [23], several parameters
confound telomere lengths in adults, thus, in contrast to
the findings in newborns, making also our results from
mothers difficult to interpret.
Table 4 T cell receptor excision circles (TRECs) in non-smoking (NSM) and smoking mothers (SM) and their newborns
Newborns Mothers
NSM (n = 16) SM (n = 11) NSM (n = 16) SM (n = 11)
TRECs/1000 CD4 + CD45RA + cells 103 ± 125 (69; 16 – 589)*** 166 ± 269 (55; 11 – 985)*** 32 ± 31 (22; 4 – 146) 51 ± 58 (20; 7 – 193)
Values are given in mean ± standard deviation (median; range).
Statistical difference (non-parametric Mann–Whitney-U test):
***p < 0.001 higher than respective maternal values.
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http://www.biomedcentral.com/1471-2431/13/57Cytokines were not altered in newborns of SM compared
to NSM. Cytokine responses to allergens were tested in a
study investigating newborns whose mothers smoked
throughout pregnancy [24]. In that study, higher but only
partly significant responses for IL-13, IL-9, IL-5 and IL-6
were seen in newborns of smoking mothers, with no
difference in IFN-γ responses. Similar to that study,
the large variation in serum cytokines may not allow
to draw clear effects of maternal smoking on newborn
cytokine production in our cohort. SM and NSM
showed higher IL-7 concentrations compared to their
newborns, which may reflect the suggested role of IL-7
for proliferation of peripheral naive T cells to maintain the
peripheral T cell pool in adults [25,26].
Interestingly, SM had higher absolute lymphocyte
numbers, which was also shown by others [27]. In
contrast to other studies [27,28], proportions of CD3+ [9],
CD4+ and CD8+ T cells, with an emphasis of CD4+
memory T cells [29], and B cells were not increased, as
well as CD4 + CD25++ T cells were not decreased in
SM in our study. Influences of dose, duration of smoke
exposure and the ethnic background have been suggestedmother newborn
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Figure 2 Relative telomere length (RTL) in non-smoking (NSM)
and smoking mothers (SM) and newborns. Newborns of SM had
significantly longer telomeres than newborns of NSM (** p < 0.01).
Regardless of smoking habits, mothers had shorter telomeres than
their respective newborns (*** p < 0.001). Non-parametric Mann–
Whitney-U test.to cause the heterogeneity in the findings [30], as well as
redistribution of specific lymphocyte subpopulations from
the periphery to other compartments, e.g. the bronchial
lining associated with cigarette smoking [31,32]. CD4 +
CD25++ T cells do not necessarily consist of Tregs, but
contribute also to the naive and activated T cell pool.
Thus, for comparability with other studies [9], Foxp3
should be included in further studies to define truly
regulatory T cells. Overall, no difference in the investigated
lymphocyte subpopulations was seen between SM and
NSM. These findings are similar to a study investigating
acute effects of smoking and environmental tobacco smoke
in five smokers and non-smokers [33], showing increased
NK cells and decreased CD3+ and CD19+ cells which
did not reach statistical significance. However, our
results may be limited by the markers used to define
the different lymphocyte subpopulations. Possibly, more
differences between newborns of SM and NSM would
have been revealed by investigating markers which are
linked to more functional features of lymphocytes, such as
expression of chemokine receptors, activation markers
and intracellular cytokine production.
One strength of our study is the strict inclusion criteria,
including only vaginally delivered term newborns with full
maturity signs and no pre- or perinatal distress, to exclude
changes of lymphocyte subpopulations caused by different
gestational age, maturity or potential inflammatory mech-
anisms [34]. However, one drawback of our investigation
remains, that serum cotinine concentrations rather reflect
acute exposure to cigarette smoke than its long term
effects. Thus it could be that women, who did not
smoke for a few days immediately before birth may have
had inappropriately low serum cotinine concentrations
whereas women passively or actively exposed during
that time exhibited peak cotinine levels. Because of
this and the known uncertainties of patient history
taking, future studies should try to more adequately
determine “true” cigarette smoke exposure, for example
by measuring cotinine concentrations in the hairs from
mothers and newborns [35].
Conclusions
Thus, although our results did not reveal striking differ-
ences between newborns of SM and NSM, our finding
of significantly increased RTLs in smoke-exposed
newborns may be an important indication that cigarette
Almanzar et al. BMC Pediatrics 2013, 13:57 Page 7 of 8
http://www.biomedcentral.com/1471-2431/13/57smoking may cause severe cytogenetic damage in lympho-
cytes [21]. Also, expected long-term effects of maternal
smoking during pregnancy on the cytokine profile and
inflammatory potential in their offspring should cause
increased awareness.
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